Coronary risk factors and their relationship with complications of atrial fibrillation
Abstract
Introduction: Atrial fibrillation is one of the most important causes of stroke, heart failure, sudden death and cardiovascular morbidity worldwide.
Objective: To describe the relationship of coronary risk factors with complications of patients with atrial fibrillation.
Method: Descriptive, cross-sectional study; including 102 patients with a diagnosis of atrial fibrillation, admitted to the department of Cardiology of the Hospital Universitario Clínico Quirúrgico General Calixto García, from January 2019 to July 2020.
Results: Males prevailed (65.7%). A total of 77.5% of patients were hypertensive, 41.2% were overweight and 38.2% were obese. A 21.6% referred personal history of diabetes mellitus and 64.7% had increased fasting blood glucose. Some complication was observed in 58 patients, with heart failure (42.2%) and cerebral embolism (7.8%) standing out. An association between the increased risk of complications and the presence of coronary risk factors was observed. In patients with high blood pressure, the risk of complications was 7.66 times higher.
Conclusions: More than half of the patients studied presented some complication related to arrhythmia, the most frequent being heart failure. Coronary risk factors were present in most of these patients with a predominance of high blood pressure, obesity and diabetes mellitus. The presence of coronary risk factors was associated with an increased risk of complications in patients with atrial fibrillation.
Downloads
References
1. Collazo Rodríguez MP, Rodríguez Leyva D, Pérez Martín O, Cruz Cardentey M, Mengana Betancourt A. La epidemiología de la fibrilación auricular después de 390 años. CCM [Internet]. 2019 [citado 22 Abr 2021];23(2):1324-37. Disponible en: http://revcocmed.sld.cu/index.php/cocmed/article/view/2566/1416
2. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. DOI: https://doi.org/10.1093/eurheartj/ehaa612
3. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. DOI: https://doi.org/10.1161/circulationaha.113.005119
4. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-e528. DOI: https://doi.org/10.1161/cir.0000000000000659
5. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-51. DOI: https://doi.org/10.1093/eurheartj/eht280
6. Zamorano JL. La fibrilación auricular en las guías de práctica clínica. Rev Esp Cardiol. 2016;16(A):52-4. DOI: https://doi.org/10.1016/S1131-3587(16)30015-2
7. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet. 2015;386(9989):154-62. DOI: https://doi.org/10.1016/s0140-6736(14)61774-8
8. Moreno LE, Hernández IT, Moreno R, García G, Suárez R. Fibrilación auricular en pacientes con ictus isquémico en Hospital Universitario Comandante Faustino Pérez. 2017. Rev Méd Electrón [Internet]. 2018 [citado 23 Abr 2021];40(2):360-70. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2636/pdf_399
9. Castro Clavijo JA, Quintero S, Valderrama F, Diaztagle JJ, Ortega J. Prevalencia de la fibrilación auricular en pacientes hospitalizados por Medicina Interna. Rev Colomb Cardiol. 2020;27(6):560-6. DOI: https://doi.org/10.1016/j.rccar.2019.01.007
10. Ministerio de Salud Pública. Anuario Estadístico de Salud 2018. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2019.
11. Wilkinson C, Todd O, Clegg A, Gale CP, Hall M. Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing. 2019;48(2):196-203. DOI: https://doi.org/10.1093/ageing/afy180
12. Lago Santiesteban D, Lago Santiesteban Y, Bárzaga Morell S, Iglesias Pérez O, Vega Torres R. Factores de riesgo de enfermedad cerebrovascular isquémica en pacientes con fibrilación auricular. MULTIMED [Internet]. 2016 [citado 23 Abr 2021];20(3):518-42. Disponible en: http://www.revmultimed.sld.cu/index.php/mtm/article/view/198/227
13. Rodríguez Jiménez AE, Cruz Inerarity H, Toledo Rodríguez E, Quintana Cañizares G. Fibrilación auricular de novo ¿incrementa la mortalidad intrahospitalaria en el infarto miocárdico con elevación del ST? Rev Finlay [Internet]. 2017 [citado 24 Abr 2021];7(4):240-9. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/547/1618
14. Fernández González EM, Figueroa Oliva DA. Tabaquismo y su relación con las enfermedades cardiovasculares. Rev Habanera Cienc Méd [Internet]. 2018 [citado 24 Abr 2021];17(2):225-35. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2044/2069
15. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Rev Cuban Med [Internet]. 2017 [citado 18 Sep 2019];56(4):242-321. Disponible en: http://scielo.sld.cu/pdf/med/v56n4/med01417.pdf
16. Verdecchia P, Angeli F, Reboldi G. Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies. Circ Res. 2018;122(2):352-68. DOI: https://doi.org/10.1161/circresaha.117.311402
17. Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LY, Loehr LR, et al. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA Cardiol. 2016;1(4):433-41. DOI: https://doi.org/10.1001/jamacardio.2016.1025
18. Tikhonoff V, Kuznetsova T, Thijs L, Cauwenberghs N, Stolarz-Skrzypek K, Seidlerová J, et al. Ambulatory blood pressure and long-term risk for atrial fibrillation. Heart. 2018;104(15):1263-70. DOI: https://doi.org/10.1136/heartjnl-2017-312488
19. Goire Guevara G, Cuza Díaz LA, Fournier Calzado G, González Marrero J, Montero Vega V. Factores de riesgo en complicaciones tromboembólicas cerebrales de pacientes con fibrilación auricular permanente no valvular. Rev Inf Cient [Internet]. 2019 [citado 25 Abr 2021];98(1):77-87. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/2207/3966
20. Guerra García D, Valladares Carvajal F, Bernal Valladares EJ, Díaz Quiñones JA. Factores de riesgo asociados a ictus cardioembólico en pacientes con fibrilación auricular no valvular. Rev Finlay [Internet]. 2018 [citado 25 Abr 2021];8(1):9-17. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/577/1640
21. Pouwels S, Topal B, Knook MT, Celik A, Sundbom M, Ribeiro R, et al. Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management. Expert Rev Cardiovasc Ther. 2019;17(3):209-23. DOI: https://doi.org/10.1080/14779072.2019.1581064
22. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69. DOI: https://doi.org/10.1016/j.jacc.2015.03.002
23. Proietti M, Guiducci E, Cheli P, Lip GY. Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. Stroke. 2017;48(4):857-66. DOI: https://doi.org/10.1161/strokeaha.116.015984
24. Kachur S, Lavie CJ, de Schutter A, Milani RV, Ventura HO. Obesity and cardiovascular diseases. Minerva Med. 2017;108(3):212-28. DOI: https://doi.org/10.23736/s0026-4806.17.05022-4
25. Cinza Sanjurjo S, Prieto Díaz MA, Llisterri Caro JL, Barquilla García A, Rodríguez Padial L, Vidal Pérez R, et al. Prevalencia de obesidad y comorbilidad cardiovascular asociada en los pacientes incluidos en el estudio IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal). Semergen. 2019;45(5):311-22. DOI: https://doi.org/10.1016/j.semerg.2018.11.003
26. Cañón Montañez W, Santos A, Nunes LA, Pires JC, Freire C, Ribeiro AL, et al. La obesidad central es el componente clave en la asociación del síndrome metabólico con el deterioro del strain longitudinal global del ventrículo izquierdo. Rev Esp Cardio. 2018;71(7):524-30. DOI: https://doi.org/10.1016/j.recesp.2017.08.023
27. Ávila Cortez IR. Factores de riesgo prevalentes para fibrilación auricular en pacientes adultos [Tesis]. Universidad Nacional de Trujillo [Internet]; 2020 [citado 28 Abr 2021]. Disponible en: https://dspace.unitru.edu.pe/handle/UNITRU/16171
28. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133(24):2459-502. DOI: https://doi.org/10.1161/circulationaha.116.022194
29. Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F, et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression. PLoS One [Internet]. 2017 [citado 28 Abr 2021];12(3):e0170955. Disponible en: https://doi.org/10.1371/journal.pone.0170955
30. O'Neal WT, Nazarian S, Alonso A, Heckbert SR, Vaccarino V, Soliman EZ. Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). Endocrine. 2017;58(1):91-6. DOI: https://doi.org/10.1007/s12020-017-1385-3
31. Azcuy Ruiz M, Sandrino Sánchez M, Lima Fuentes L, Valle González D, González Landeiro F. Factores de riesgo hemorrágico según HAS-BLED en pacientes con fibrilación auricular no valvular. Rev Cienc Méd Pinar Río [Internet]. 2020 [citado 28 Abr 2021];24(4):e4371. Disponible en: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/4371/pdf
32. Vitón Castillo AA, Rego Ávila H. Consideraciones fisiopatológicas y diagnósticas sobre la fibrilación auricular. Rev Cuban Med Int Emerg [Internet]. 2020 [citado 28 Abr 2021];19(2):e699. Disponible en: http://www.revmie.sld.cu/index.php/mie/article/view/699
33. Miller JD, Aronis KN, Chrispin J, Patil KD, Marine JE, Martin SS, et al. Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation. J Am Coll Cardiol. 2015;66(25):2899-906. DOI: https://doi.org/10.1016/j.jacc.2015.10.047
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
